Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development

被引:162
作者
Okamoto, Mina [1 ]
Murai, Junko [1 ]
Yoshikawa, Hideki [1 ]
Tsumaki, Noriyuki [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan
关键词
bone morphogenetic proteins; noggin; osteoclasts; endochondral bone formation; transgenic mice;
D O I
10.1359/JBMR.060411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Bone morphogenetic proteins (BMPs) act on various types of cells. Although involvement of BMP signals in osteoblast differentiation has been studied extensively, the effects of BMPs on osteoclasts have not been widely researched. Consequently, the net effects of BMPs on bone remain unclear. The purpose of this study was to delineate more fully the role of BMPs in skeletal biology. Materials and Methods: We generated transgenic mice that express BMP4 or noggin in bone under the control of the 2.3-kb alpha 1(I) collagen chain gene (Col1a1) promoter, and analyzed their bone phenotype. We also analyzed bone of transgenic mice expressing BMP4 specifically in cartilage. Results: Mice overexpressing BMP4 in bone developed severe osteopenia with increased osteoclast number. Mice overexpressing noggin, a BMP antagonist, in bone showed increased bone volume associated with decreased bone formation rate and decreased osteoclast number. The noggin-transgenic tibias exhibited reduced periosteal bone formation and reduced resorption of immature bone in marrow spaces, associated with frequent fractures at the diaphysis. Co-culture of primary osteoblasts prepared from noggin-transgenic calvariae and wildtype spleen cells resulted in poor osteoclast formation, which was rescued by addition of recombinant BMP2, suggesting that noggin inhibits osteoclast formation by attenuating BMP activities in noggin-transgenic mice. The expression levels of Rankl were not decreased in primary osteoblasts from noggin transgenic mice. Immunoblot analysis showed increased phosphorylation of Smad1/5/8 in osteoclast precursor cells after 20-minute treatment with BMPs, suggesting that these cells are stimulated by BMPs. Mice overexpressing BMP4 in cartilage had enlarged bones containing thick trabeculae, possibly because of expansion of cartilage anlagen. Conclusions: Overexpression of noggin in bone revealed that BMP signals regulate bone development through stimulation of osteoblasts and osteoclasts.
引用
收藏
页码:1022 / 1033
页数:12
相关论文
共 34 条
[1]   Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: Antagonism by noggin [J].
Abe, E ;
Yamamoto, M ;
Taguchi, Y ;
Lecka-Czernik, B ;
O'Brien, CA ;
Economides, AN ;
Stahl, N ;
Jilka, RL ;
Manolagas, SC .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) :663-673
[2]   The bone morphogenetic proteins antagonist noggin inhibits membranous ossification [J].
Aspenberg, P ;
Jeppsson, C ;
Economides, AN .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (03) :497-500
[3]   Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators [J].
Balemans, W ;
Van Hul, W .
DEVELOPMENTAL BIOLOGY, 2002, 250 (02) :231-250
[4]   Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton [J].
Brunet, LJ ;
McMahon, JA ;
McMahon, AP ;
Harland, RM .
SCIENCE, 1998, 280 (5368) :1455-1457
[5]   Bone morphogenetic proteins, their antagonists, and the skeleton [J].
Canalis, E ;
Economides, AN ;
Gazzerro, E .
ENDOCRINE REVIEWS, 2003, 24 (02) :218-235
[6]   Mouse α1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast [J].
Dacquin, R ;
Starbuck, M ;
Schinke, T ;
Karsenty, G .
DEVELOPMENTAL DYNAMICS, 2002, 224 (02) :245-251
[7]   Skeletal overexpression of noggin results in osteopenia and reduced bone formation [J].
Devlin, RD ;
Du, Z ;
Pereira, RC ;
Kimble, RB ;
Economides, AN ;
Jorgetti, V ;
Canalis, E .
ENDOCRINOLOGY, 2003, 144 (05) :1972-1978
[8]   Clinical applications of recombinant human BMPs: Early experience and future development [J].
Einhorn, TA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A :82-88
[9]  
Friedberg T, 2001, Am J Pharmacogenomics, V1, P83, DOI 10.2165/00129785-200101020-00001
[10]   Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures -: A prospective, controlled, randomized study of four hundred and fifty patients [J].
Govender, S ;
Csimma, C ;
Genant, HK ;
Valentin-Opran, A ;
Amit, Y ;
Arbel, R ;
Aro, H ;
Atar, D ;
Bishay, M ;
Börner, MG ;
Chiron, P ;
Choong, P ;
Cinats, J ;
Courtenay, B ;
Feibel, R ;
Geulette, B ;
Gravel, C ;
Haas, N ;
Raschke, M ;
Hammacher, E ;
van der Velde, D ;
Hardy, P ;
Holt, M ;
Josten, C ;
Ketterl, RL ;
Lindeque, B ;
Lob, G ;
Mathevon, H ;
Mccoy, G ;
Marsh, D ;
Miller, R ;
Munting, E ;
Oevre, S ;
Nordsletten, L ;
Patel, A ;
Pohl, A ;
Rennie, W ;
Reynders, P ;
Rommens, PM ;
Rondia, J ;
Rossouw, WC ;
Daneel, PJ ;
Ruff, S ;
Rüter, A ;
Santavirta, S ;
Schildhauer, TA ;
Gekle, C ;
Schnettler, R ;
Segal, D ;
Seiler, H .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (12) :2123-2134